HC Wainwright Initiates Aptorum On Upcoming “Innovative Pipeline”
HC Wainwright initiated coverage on Aptorum Group Limited (NASDAQ:APM) with a Buy rating and a price target of $8. The analyst is…
HC Wainwright & Co. Initiates Coverage On Aptorum Gr with Buy Rating, Announces Price Target of $8
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Aptorum Gr (NASDAQ:APM) with a Buy rating and announces Price Target of $8.
Aptorum Group Updates On The Clinical Validation Of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics
Aptorum Group Limited (NASDAQ:APM, PARIS:APM) a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune diseases and infectious diseases, is pleased to announce further
